PL2457905T3 - Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych - Google Patents

Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych

Info

Publication number: PL2457905T3
Authority: PL; Poland
Prior art keywords: purification; synthesis; methods; diaminophenothiazinium compounds; diaminophenothiazinium
Prior art date: 2006-07-11

Application number

PL11173338T

Other languages

English (en)

Inventor

Claude Michel Wischik

John Mervyn David Storey

Colin Marshall

James Peter Sinclair

Thomas Craven Baddeley

Original Assignee

Wista Laboratories Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-11

Filing date

2007-07-10

Publication date

2017-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38669650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2457905(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-07-10 Application filed by Wista Laboratories Ltd. filed Critical Wista Laboratories Ltd.

2017-02-28 Publication of PL2457905T3 publication Critical patent/PL2457905T3/pl

Links

KPYHKEZPEDJERZ-UHFFFAOYSA-N 10h-phenothiazine-1,2-diamine Chemical class C1=CC=C2NC3=C(N)C(N)=CC=C3SC2=C1 KPYHKEZPEDJERZ-UHFFFAOYSA-N 0.000 title 1
230000015572 biosynthetic process Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
238000000746 purification Methods 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B21/00—Thiazine dyes
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0096—Purification; Precipitation; Filtration
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

PL11173338T 2006-07-11 2007-07-10 Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych PL2457905T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81962706P	2006-07-11	2006-07-11

Publications (1)

Publication Number	Publication Date
PL2457905T3 true PL2457905T3 (pl)	2017-02-28

Family

ID=38669650

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL16173815T PL3121169T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych
PL11173338T PL2457905T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych
PL07733509T PL2057136T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazynowych
PL11173334T PL2457904T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazynowych

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL16173815T PL3121169T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PL07733509T PL2057136T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazynowych
PL11173334T PL2457904T3 (pl)	2006-07-11	2007-07-10	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazynowych

Country Status (16)

Country	Link
US (10)	US7956183B2 (pl)
EP (5)	EP2057136B1 (pl)
JP (2)	JP5350237B2 (pl)
CN (2)	CN101511803B (pl)
AU (1)	AU2007274057B2 (pl)
CA (1)	CA2657352C (pl)
CY (1)	CY1118184T1 (pl)
DK (4)	DK2057136T3 (pl)
ES (4)	ES2421930T3 (pl)
HU (1)	HUE030621T2 (pl)
LT (1)	LT2457905T (pl)
MY (2)	MY148145A (pl)
PL (4)	PL3121169T3 (pl)
PT (4)	PT2457905T (pl)
SI (4)	SI2057136T1 (pl)
WO (1)	WO2008007074A2 (pl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI2322517T1 (sl)	2004-09-23	2019-06-28	Wista Laboratories Ltd.	Postopki za kemijsko sintezo in čiščenje diaminofenotiazinijevih spojin, vključno metiltioninijevega klorida (MTC)
ES2349322T7 (es)	2006-03-29	2019-10-17	Wista Lab Ltd	Sales de 3,7-diamino-10H-fenotiazina y su utilización
MY148145A (en)	2006-07-11	2013-03-15	Wista Lab Ltd	Methods of synthesis and/or purification of diaminophenothiazinium compounds
FR2903696B1 (fr)	2006-07-12	2011-02-11	Provence Technologies	Procede de purification de composes diaminophenothiazium
AU2008265045B2 (en) *	2007-06-19	2014-02-27	Taurx Therapeutics Management Ltd.	Phenothiazine compounds for treating Mild Cognitive Impairment
CA2701075C (en) *	2007-10-03	2019-02-12	Wista Laboratories Ltd.	Therapeutic use of diaminophenothiazines.
ES2420118T3 (es) *	2008-12-09	2013-08-22	Interquim, S.A.	Procedimiento para la preparación de (6S)-(-)-5,6,7,8-tetrahidro-6-[propil-(2-tienil)etil]amino-1-naftol (Rotigotina)
JP5868955B2 (ja)	2010-04-30	2016-02-24	プロセッタアンチバイラルインコーポレイテッド	抗ウイルス化合物
DE102010062810B4 (de) *	2010-09-07	2014-03-13	Immungenetics Ag	2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien
JP5898701B2 (ja)	2011-02-11	2016-04-13	ウィスタラボラトリーズリミテッド	フェノチアジンジアミニウム塩およびそれらの使用
EP2699241B1 (en)	2011-04-20	2016-07-27	Prosetta Antiviral Inc.	Antiviral compounds
RU2535073C1 (ru) *	2013-07-18	2014-12-10	Федеральное государственное бюджетное учреждение науки "Научно-исследовательский институт общей реаниматологии имени В.А. Неговского" Российской академии медицинских наук	Способ лечения метгемоглобинемии
CN105612148B (zh) *	2013-08-15	2018-09-14	益友制药私人有限公司	用于纯化二氨基吩噻嗪化合物的方法
GB201317702D0 (en) *	2013-10-07	2013-11-20	Wista Lab Ltd	Methods of chemical synthesis of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
FR3015481B1 (fr) *	2013-12-20	2016-08-12	Etat Francais Represente Par Le Delegue General Pour L'armement	Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite
CN103864717B (zh) *	2014-04-04	2015-11-11	山东理工大学	一种针状亚甲基白晶体的制备方法
US10472340B2 (en)	2015-02-17	2019-11-12	Arizona Board Of Regents On Behalf Of Arizona State University	Substituted phenothiazines as mitochondrial agents
AU2016220153B2 (en)	2015-02-17	2020-07-02	Arizona Board Of Regents On Behalf Of Arizona State University	Therapeutic compounds
GB201512678D0 (en)	2015-07-20	2015-08-26	Wista Lab Ltd	Methods of chemical synthesis
CN105399703B (zh) *	2015-12-15	2018-02-13	江苏恒润制药有限公司	一种亚甲基蓝的制备方法
CN105541756B (zh) *	2015-12-17	2018-02-09	陕西方舟制药有限公司	一种制备1‑(3，7‑双二甲氨基‑吩噻嗪‑10‑基)乙酮的方法
ITUA20163526A1 (it)	2016-05-17	2017-11-17	Icrom Spa	Procedimento per la preparazione di composti diamminofenotiazinici ad elevato grado di purezza
JP7073330B2 (ja)	2016-07-25	2022-05-23	ウィスタラボラトリーズリミテッド	ジアミノフェノチアジンの投与及び投与量
US10745366B2 (en)	2016-08-25	2020-08-18	Arizon Board Of Regents On Behalf Of Arizona State University	Therapeutic compounds
US12570622B2 (en)	2016-08-25	2026-03-10	Arizona Board Of Regents On Behalf Of Arizona State University	Therapeutic compounds
US11390605B2 (en)	2016-08-25	2022-07-19	Arizona Board Of Regents On Behalf Of Arizona State University	Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
GB201614834D0 (en)	2016-09-01	2016-10-19	Wista Lab Ltd	Treatment of dementia
GB201621817D0 (en)	2016-12-21	2017-02-01	Wista Lab Ltd	Methods of chemical synthesis
US11413240B2 (en)	2016-12-29	2022-08-16	Board Of Regents, The University Of Texas System	Methylene blue solution for the treatment of oral lesions
CN110505906A (zh) *	2017-01-10	2019-11-26	得克萨斯州A&M大学系统	甲磺酸介导的共轭多孔聚合物网络的无溶剂合成
FR3063495B1 (fr) *	2017-03-02	2019-04-05	Provepharm Life Solutions	Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium
EP3375777A1 (en)	2017-03-15	2018-09-19	MIKROCHEM spol. s.r.o.	Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide
FI4385512T3 (fi)	2018-07-26	2026-01-12	Taurx Therapeutics Man Ltd	Diaminofenotiatsiinien optimoitu annostus populaatioille
US11350853B2 (en)	2018-10-02	2022-06-07	Under Armour, Inc.	Gait coaching in fitness tracking systems
CN109337681B (zh) *	2018-11-22	2020-05-08	南京工业大学	一种硫氮共掺杂的碳量子点的制备方法和应用
TR201818670A2 (tr)	2018-12-05	2020-06-22	Eti Gida Sanayi Ve Ticaret Anonim Sirketi	Sızıntı yapmayan gıda dolgu maddesi depozitör sistemi.
US12215234B2 (en) *	2019-09-21	2025-02-04	RK Pharma Solutions LLC	Process for the purification of methylene blue
WO2021171235A1 (en) *	2020-02-28	2021-09-02	Dishman Carbogen Amcis Ltd	A process for the preparation of methylene blue
US12280062B2 (en)	2021-02-24	2025-04-22	Zydus Lifesciences Limited	Parenteral compositions comprising methylene blue
CN114806211B (zh) *	2022-03-16	2023-04-07	深圳先进技术研究院	一种疏水性亚甲蓝荧光染料及其制备方法和应用
CN114656424B (zh) *	2022-03-16	2023-06-27	深圳先进技术研究院	一种上转换长余辉化学发光成像纳米探针及其制备方法和应用
CN116947783B (zh) *	2022-04-19	2026-04-17	英科隆生物技术（杭州）有限公司	一种电子媒介体的提纯方法
US20250270177A1 (en) *	2022-04-19	2025-08-28	Leadway (Hk) Limited	Purification method for electron mediator
CN114507193B (zh) *	2022-04-19	2022-06-24	英科隆生物技术（杭州）有限公司	电子媒介体天青c的提纯方法
AU2023279800A1 (en)	2022-05-31	2024-12-19	TauRx Therapeutics Management Ltd	Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds
CN114989113A (zh) *	2022-06-01	2022-09-02	山东科源制药股份有限公司	一种药用亚甲基蓝的精制方法
EP4590306A1 (en)	2022-09-21	2025-07-30	Yin Sze Loh	Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases
US20240115579A1 (en)	2022-09-22	2024-04-11	Galenicum Health S.L.U.	Pharmaceutical compositions and manufacturing methods thereof
EP4342451A1 (en)	2022-09-22	2024-03-27	Galenicum Health SLU	Pharmaceutical compositions and manufacturing methods thereof
CN117447421A (zh) *	2023-10-30	2024-01-26	上海沃凯生物技术有限公司	一种3,7-双-（二甲胺基）-吩噻嗪的合成方法
CN119823064B (zh) *	2025-01-03	2025-12-30	仁合益康集团有限公司	一种亚甲蓝的制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1886C (de)	1877-12-15	1877-12-15	Basf Ag	Verfahren zur darstellung blauer farbstoffe aus dimethylanilin und anderen tertiaeren aromatischen monaminen
DE103147C (de) *	1898-06-07	1899-04-05	Cohn Georg	Verfahren zur darstellung von acetylleukomethylenblau und -äthylenblau.
DE113721C (de) *	1899-06-01	1900-09-28		Verfahren zur Darstellung von Acidylderivaten der Leukothioninfarbstoffe
US3395018A (en) *	1964-04-29	1968-07-30	Du Pont	Light-sensitive color-forming composition
US3641016A (en) *	1968-02-16	1972-02-08	Egyt Gyogyszervegyeszeti Gyar	Thionine derivatives
DE2515966C3 (de)	1975-04-11	1979-11-22	Boehringer Mannheim Gmbh, 6800 Mannheim	Vorgefärbte Objektträger für die Blutunte rsuchung
US4003892A (en)	1975-04-17	1977-01-18	Serva-Entwicklungslabor V. Grothe & Co.	Method of separating thionine and its N-methyl derivatives from each other
US4212971A (en)	1979-03-08	1980-07-15	American Cyanamid Company	Process for preparing methylene blue
JPS6385644A (ja) *	1986-09-30	1988-04-16	Ricoh Co Ltd	電子写真現像剤用トナ−
US5344928A (en)	1991-04-26	1994-09-06	Takeda Chemical Industries, Ltd.	Phenothiazine derivatives, their production and use
US6238931B1 (en) *	1993-09-24	2001-05-29	Biosite Diagnostics, Inc.	Fluorescence energy transfer in particles
GB9506197D0 (en)	1995-03-27	1995-05-17	Hoffmann La Roche	Inhibition of tau-tau association.
WO1998031219A1 (en)	1997-01-21	1998-07-23	The American National Red Cross	Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
JP2000344685A (ja)	1999-03-26	2000-12-12	Bf Kenkyusho:Kk	アズールａ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物
IT1307270B1 (it)	1999-10-12	2001-10-30	Dideco Spa	Procedimento e dispositivo per la determinazione della concentrazionedi eparina in un campione di fluido.
CA2401624C (en) *	2000-02-26	2011-08-16	Merrill A. Biel	Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
FR2810318B1 (fr)	2000-06-15	2005-09-23	Laurent Galey	Derives de diamano-phenothiazine
GB0101049D0 (en)	2001-01-15	2001-02-28	Univ Aberdeen	Materials and methods relating to protein aggregation in neurodegenerative disease
GB2373787A (en)	2001-03-08	2002-10-02	Univ Central Lancashire	Phenothiazinium derivatives and their use to reduce pathogenic contaminants
GB0106953D0 (en)	2001-03-20	2001-05-09	Univ Aberdeen	Neufofibrillary labels
GB0113121D0 (en)	2001-05-30	2001-07-18	Univ Leeds	Biologically active photosensitisers
US7176308B2 (en) *	2002-06-17	2007-02-13	Verification Technologies, Inc.	Processes for preparing novel methylene blue derivative
GB0322756D0 (en)	2003-09-29	2003-10-29	Univ Aberdeen	Methods of chemical synthesis
EP1687286A1 (en) *	2003-11-28	2006-08-09	Photopharmica Limited	Developments in biologically active methylene blue derivatives (2)
SI2322517T1 (sl)	2004-09-23	2019-06-28	Wista Laboratories Ltd.	Postopki za kemijsko sintezo in čiščenje diaminofenotiazinijevih spojin, vključno metiltioninijevega klorida (MTC)
CN101084204B (zh)	2004-09-23	2012-12-05	卫思道制药有限公司	包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
ES2349322T7 (es)	2006-03-29	2019-10-17	Wista Lab Ltd	Sales de 3,7-diamino-10H-fenotiazina y su utilización
MY148145A (en) *	2006-07-11	2013-03-15	Wista Lab Ltd	Methods of synthesis and/or purification of diaminophenothiazinium compounds
FR2903696B1 (fr)	2006-07-12	2011-02-11	Provence Technologies	Procede de purification de composes diaminophenothiazium
JP5898701B2 (ja)	2011-02-11	2016-04-13	ウィスタラボラトリーズリミテッド	フェノチアジンジアミニウム塩およびそれらの使用
JP7073330B2 (ja)	2016-07-25	2022-05-23	ウィスタラボラトリーズリミテッド	ジアミノフェノチアジンの投与及び投与量
GB201614834D0 (en)	2016-09-01	2016-10-19	Wista Lab Ltd	Treatment of dementia
GB201621817D0 (en)	2016-12-21	2017-02-01	Wista Lab Ltd	Methods of chemical synthesis
FI4385512T3 (fi)	2018-07-26	2026-01-12	Taurx Therapeutics Man Ltd	Diaminofenotiatsiinien optimoitu annostus populaatioille
GB201909454D0 (en)	2019-07-01	2019-08-14	Wista Lab Ltd	Enhancers
GB201909506D0 (en)	2019-07-02	2019-08-14	Wista Lab Ltd	Synaptopathies

2007
- 2007-07-10 MY MYPI20090099A patent/MY148145A/en unknown
- 2007-07-10 CN CN2007800336078A patent/CN101511803B/zh active Active
- 2007-07-10 PT PT111733382T patent/PT2457905T/pt unknown
- 2007-07-10 SI SI200731284T patent/SI2057136T1/sl unknown
- 2007-07-10 PL PL16173815T patent/PL3121169T3/pl unknown
- 2007-07-10 LT LTEP11173338.2T patent/LT2457905T/lt unknown
- 2007-07-10 EP EP07733509.9A patent/EP2057136B1/en active Active
- 2007-07-10 PT PT77335099T patent/PT2057136E/pt unknown
- 2007-07-10 SI SI200732186T patent/SI3121169T1/sl unknown
- 2007-07-10 AU AU2007274057A patent/AU2007274057B2/en active Active
- 2007-07-10 ES ES07733509T patent/ES2421930T3/es active Active
- 2007-07-10 PT PT111733341T patent/PT2457904E/pt unknown
- 2007-07-10 CN CN201210195299.1A patent/CN102718730B/zh active Active
- 2007-07-10 DK DK07733509.9T patent/DK2057136T3/da active
- 2007-07-10 PT PT161738158T patent/PT3121169T/pt unknown
- 2007-07-10 US US12/373,216 patent/US7956183B2/en active Active
- 2007-07-10 ES ES11173334.1T patent/ES2529714T3/es active Active
- 2007-07-10 PL PL11173338T patent/PL2457905T3/pl unknown
- 2007-07-10 WO PCT/GB2007/002570 patent/WO2008007074A2/en not_active Ceased
- 2007-07-10 ES ES11173338.2T patent/ES2603783T3/es active Active
- 2007-07-10 CA CA2657352A patent/CA2657352C/en active Active
- 2007-07-10 EP EP16173815.8A patent/EP3121169B1/en active Active
- 2007-07-10 JP JP2009518955A patent/JP5350237B2/ja active Active
- 2007-07-10 EP EP11173338.2A patent/EP2457905B1/en active Active
- 2007-07-10 DK DK11173338.2T patent/DK2457905T3/en active
- 2007-07-10 PL PL07733509T patent/PL2057136T3/pl unknown
- 2007-07-10 SI SI200731596T patent/SI2457904T1/sl unknown
- 2007-07-10 ES ES16173815T patent/ES2912571T3/es active Active
- 2007-07-10 MY MYPI2012001462A patent/MY162313A/en unknown
- 2007-07-10 SI SI200731836A patent/SI2457905T1/sl unknown
- 2007-07-10 DK DK16173815.8T patent/DK3121169T3/da active
- 2007-07-10 EP EP22153513.1A patent/EP4063354A1/en active Pending
- 2007-07-10 PL PL11173334T patent/PL2457904T3/pl unknown
- 2007-07-10 HU HUE11173338A patent/HUE030621T2/en unknown
- 2007-07-10 DK DK11173334.1T patent/DK2457904T3/en active
- 2007-07-10 EP EP11173334.1A patent/EP2457904B1/en active Active
2011
- 2011-05-31 US US13/149,164 patent/US8440821B2/en active Active
2013
- 2013-05-09 US US13/890,607 patent/US9382220B2/en active Active
- 2013-08-21 JP JP2013171087A patent/JP6243659B2/ja active Active
2016
- 2016-06-17 US US15/185,803 patent/US9675621B2/en active Active
- 2016-11-03 CY CY20161101128T patent/CY1118184T1/el unknown
2017
- 2017-06-09 US US15/619,199 patent/US9980971B2/en active Active
2018
- 2018-05-23 US US15/987,354 patent/US10525061B2/en active Active
2019
- 2019-11-15 US US16/685,420 patent/US11045477B2/en active Active
2021
- 2021-06-23 US US17/355,336 patent/US11878021B2/en active Active
2023
- 2023-12-08 US US18/533,515 patent/US20240115580A1/en not_active Abandoned
2025
- 2025-01-08 US US19/013,969 patent/US20250222006A1/en active Pending

Also Published As

Publication number	Publication date
JP2009542786A (ja)	2009-12-03
DK2457904T3 (en)	2015-01-12
HK1129675A1 (en)	2009-12-04
EP2457905A1 (en)	2012-05-30
PL3121169T3 (pl)	2022-05-23
US11878021B2 (en)	2024-01-23
AU2007274057A1 (en)	2008-01-17
EP3121169A1 (en)	2017-01-25
EP2057136A2 (en)	2009-05-13
US20160296531A1 (en)	2016-10-13
MY148145A (en)	2013-03-15
US20130317012A1 (en)	2013-11-28
US20250222006A1 (en)	2025-07-10
JP2013253095A (ja)	2013-12-19
EP2457904B1 (en)	2014-11-19
CN101511803B (zh)	2012-10-31
WO2008007074A2 (en)	2008-01-17
CN101511803A (zh)	2009-08-19
DK2057136T3 (da)	2013-08-26
US9675621B2 (en)	2017-06-13
SI2457904T1 (sl)	2015-02-27
PL2457904T3 (pl)	2015-04-30
US20200261465A1 (en)	2020-08-20
EP3121169B1 (en)	2022-02-09
ES2603783T3 (es)	2017-03-01
EP2457904A1 (en)	2012-05-30
US10525061B2 (en)	2020-01-07
US7956183B2 (en)	2011-06-07
PT2457905T (pt)	2016-11-24
CN102718730A (zh)	2012-10-10
PL2057136T3 (pl)	2013-10-31
EP4063354A1 (en)	2022-09-28
PT2057136E (pt)	2013-08-28
US11045477B2 (en)	2021-06-29
CY1118184T1 (el)	2017-06-28
ES2421930T3 (es)	2013-09-06
WO2008007074A3 (en)	2008-02-28
PT3121169T (pt)	2022-05-13
HUE030621T2 (en)	2017-05-29
ES2529714T3 (es)	2015-02-24
JP6243659B2 (ja)	2017-12-06
ES2912571T3 (es)	2022-05-26
US20110294795A1 (en)	2011-12-01
CA2657352A1 (en)	2008-01-17
US20170273986A1 (en)	2017-09-28
CA2657352C (en)	2019-06-11
DK2457905T3 (en)	2016-11-28
EP2057136B1 (en)	2013-05-22
US9382220B2 (en)	2016-07-05
SI3121169T1 (sl)	2022-05-31
EP2457905B1 (en)	2016-08-17
US20180263999A1 (en)	2018-09-20
AU2007274057B2 (en)	2012-12-13
LT2457905T (lt)	2016-11-10
SI2457905T1 (sl)	2016-12-30
US20090259040A1 (en)	2009-10-15
US8440821B2 (en)	2013-05-14
US20210322435A1 (en)	2021-10-21
JP5350237B2 (ja)	2013-11-27
PT2457904E (pt)	2015-02-27
US20240115580A1 (en)	2024-04-11
US9980971B2 (en)	2018-05-29
MY162313A (en)	2017-05-31
CN102718730B (zh)	2018-06-05
DK3121169T3 (da)	2022-02-28
SI2057136T1 (sl)	2013-09-30

Publication	Publication Date	Title
PL2457904T3 (pl)	2015-04-30	Sposoby syntezy i/lub oczyszczania związków diaminofenotiazynowych
IL196956A0 (en)	2009-11-18	Aza-benzofuranyl compounds and methods of use
IL197060A0 (en)	2009-11-18	Aza-benzothiophenyl compounds and methods of use
IL187361A0 (en)	2008-04-13	Methods of purifying tigecycline
IL185077A0 (en)	2007-12-03	Purification of rapamycin
PL2099796T3 (pl)	2011-10-31	Związki azaindolilowe i sposoby ich zastosowania
IL194028A0 (en)	2009-09-22	Tetrahydropyridothienopyrimidine compounds and methods of use thereof
IL185309A0 (en)	2008-02-09	Isoqunoline compounds and methods of use thereof
PL2468724T3 (pl)	2016-05-31	Synteza związków pirolidynowych
ZA200802893B (en)	2009-01-28	Purification of water
GB0608190D0 (en)	2006-06-07	Method of purification
PL2198431T3 (pl)	2013-05-31	Oczyszczanie metali
DK2392335T3 (en)	2015-06-29	Use of 24-norUDCA
ZA200900896B (en)	2010-06-30	Aza-benzofuranyl compounds and methods of use
IL184570A0 (en)	2007-10-31	Purification of oligonucleotides
TWI368621B (en)	2012-07-21	Stereoselective synthesis of β-nucleosides
ZA200901009B (en)	2010-05-26	Aza-benzothiophenyl compounds and methods of use
GB2459413A8 (en)	2011-12-21	Perfluoroparacyclophane and methods of synthesis and use thereof
GB0618703D0 (en)	2006-11-01	Synthesis of leikotriene compounds
PL2038260T3 (pl)	2011-02-28	Stereoselektywna synteza (S)-1-metylo-3-fenylopiperazyny
GB2437540B (en)	2010-12-01	Fastening of pipes
GB0602832D0 (en)	2006-03-22	Synthesis of cyanohydrins
PT1899354E (pt)	2009-06-04	Síntese de desoxibiotinil-hexametilenodiaminadota
GB0506164D0 (en)	2005-05-04	Purification of salts
GB0508200D0 (en)	2005-06-01	Purification of nanostructures